Daiichi Sankyo has the Mission to contribute to the enrichment of quality of life around the world through the creation of innovative pharmaceuticals, and through the provision of pharmaceuticals addressing diverse medical needs.
The need for quality healthcare and medicine are expected to become a critical and social concern globally in the next fifty years. In this rapidly changing environment, the Daiichi Sankyo Group strives to become a global solution provider that has a good understanding of society’s needs. This objective was the starting point when we formulated our Third Mid-Term Business Management Plan (FY2013-2017) in March 2013. Following this plan, we target to become a Global Pharma Innovator,　capable of sustainable growth, while meeting diverse medical needs throughout the world.